PDGFRB and glioblastoma: A hallmark of GBM is the activation of receptor kinase signaling pathways such as the epidermal growth factor receptor (EFGR) or the platelet-derived growth factor receptor (PDGFR), due to genomic alterations including activating mutations, amplification, or mutation [15].